semaglutide longevity news Linked to Slower Aging Via Epigenetic Clocks Retatrutide - Possibly better than
Description
Wegovy (semaglutide) belongs to a class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1s)

Over the past two decades, higher-protein diets have consistently been linked to better weight-management outcomes

The prevalence rate of sarcopenia is affected by race, sex, lifestyle, and environmental factors

This supportive option is designed to help promote energy, metabolism, and overall wellness while semaglutide remains the primary treatment

Semaglutide supports enhanced weight loss by staying in the body for a longer period than the natural GLP-1 hormone
Feng J & Jin T (2025)